Alendronic acid/colecalciferol

Alendronic acid/colecalciferol, sold under the brand name Fosamax Plus D among others, is a medication for the treatment of osteoporosis in men or in postmenopausal women.[2][1][3] It taken once per week[4][3] and is not for people taking vitamin D supplements.[4][3]

Alendronic acid/colecalciferol
Combination of
Alendronic acidBisphosphonate
ColecalciferolVitamin
Clinical data
Trade namesFosamax Plus D, Fosavance, Adrovance
AHFS/Drugs.comUK Drug Information
License data
Routes of
administration		By mouth
ATC code
Legal status
Legal status
  • UK: POM (Prescription only) [1]
  • US: ℞-only [2]
  • In general: ℞ (Prescription only)
Identifiers
KEGG

It should be taken at least 30 minutes before food or other medicines.[4][3] Alendronic acid/colecalciferol was approved for use in the United States and in the European Union in 2005.[5][4]

References
  1. "Fosavance Tablets - Summary of Product Characteristics (SmPC)". (emc). Retrieved 1 March 2020.
  2. "Fosamax Plus D- alendronate sodium and cholecalciferol tablet". DailyMed. 16 August 2019. Retrieved 1 March 2020.
  3. "Adrovance EPAR". European Medicines Agency (EMA). 26 February 2020. Retrieved 1 March 2020.
  4. "Fosavance EPAR". European Medicines Agency (EMA). 9 October 2019. Retrieved 1 March 2020.
  5. "Drug Approval Package: Fosamax Plus D (Alendronate Sodium) NDA #021762". U.S. Food and Drug Administration (FDA). 8 June 2006. Retrieved 1 March 2020.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.